Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$646M |
| 2 |
Tesla
TSLA
|
+$572M |
| 3 |
Broadcom
AVGO
|
+$521M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$478M |
| 5 |
lululemon athletica
LULU
|
+$400M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.14B |
| 2 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$861M |
| 3 |
Palantir
PLTR
|
+$730M |
| 4 |
iShares Bitcoin Trust
IBIT
|
+$576M |
| 5 |
NVIDIA
NVDA
|
+$443M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 94.35% |
| 2 | Technology | 1.74% |
| 3 | Consumer Discretionary | 0.9% |
| 4 | Financials | 0.71% |
| 5 | Communication Services | 0.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
KLC
11726
CALL
KinderCare Learning Companies
KLC
$308M
| $73K | ﹤0.01% |
+11,000
| New | +$92.3K |
|
|
EPIX
11727
CALL
DELISTED
ESSA Pharma
EPIX
| $73K | ﹤0.01% |
384,200
+8,100
| +2% | +$9.71K |
|
|
KIDZ
11728
CALL
KIDZ AI Inc Class B
KIDZ
$4.03M
| $72.8K | ﹤0.01% |
+8
| New | +$107K |
|
|
APLT
11729
PUT
DELISTED
Applied Therapeutics
APLT
| $72.8K | ﹤0.01% |
121,300
+95,400
| +368% | +$44.9K |
|
11730
Acurx Pharmaceuticals
ACXP
$6.19M
| $72.1K | ﹤0.01% |
16,815
+13,328
| +382% | +$80.4K |
|
11731
CALL
Vista Gold
VGZ
$323M
| $72K | ﹤0.01% |
33,800
+18,200
| +117% | +$23.7K |
|
11732
CALL
Satellogic
SATL
$746M
| $71.8K | ﹤0.01% |
21,900
-10,400
| -32% | -$36.7K |
|
|
LAR
11733
CALL
Lithium Argentina AG
LAR
$1.13B
| $71.8K | ﹤0.01% |
+21,500
| New | +$65K |
|
11734
Taysha Gene Therapies
TSHA
$1.88B
| $71.1K | ﹤0.01% |
21,742
-190,830
| -90% | -$540K |
|
11735
Harte-Hanks
HHS
$32.4M
| $71K | ﹤0.01% |
+19,139
| New | +$69.1K |
|
11736
Bridgeline Digital
BLIN
$12.4M
| $71K | ﹤0.01% |
54,188
-15,198
| -22% | -$21.4K |
|
11737
Heritage Global
HGBL
$43M
| $70.9K | ﹤0.01% |
+42,738
| New | +$85.6K |
|
11738
CALL
PetMed Express
PETS
$40.8M
| $70.5K | ﹤0.01% |
28,100
-171,500
| -86% | -$531K |
|
11739
PUT
TechTarget
TTGT
$281M
| $70.3K | ﹤0.01% |
12,100
-11,300
| -48% | -$74.9K |
|
11740
Compass Therapeutics
CMPX
$432M
| $69.9K | ﹤0.01% |
19,960
-107,312
| -84% | -$339K |
|
11741
PUT
AXT Inc
AXTI
$3.84B
| $69.6K | ﹤0.01% |
+15,500
| New | +$44.3K |
|
|
BRY
11742
PUT
DELISTED
Berry Corp
BRY
| $69.6K | ﹤0.01% |
18,400
-7,200
| -28% | -$23.3K |
|
11743
Valaris Ltd Warrants
VAL.WS
$845M
| $69.2K | ﹤0.01% |
24,709
+9,348
| +61% | +$32K |
|
11744
CALL
Tiziana Life Sciences
TLSA
$129M
| $69.1K | ﹤0.01% |
+32,000
| New | +$59.2K |
|
11745
Sono-Tek
SOTK
$76.9M
| $69K | ﹤0.01% |
15,410
+3,389
| +28% | +$12.3K |
|
11746
PUT
Arena Group
AREN
$53.3M
| $68.9K | ﹤0.01% |
12,600
-28,800
| -70% | -$179K |
|
11747
Aclaris Therapeutics
ACRS
$885M
| $68.8K | ﹤0.01% |
36,237
-84,910
| -70% | -$148K |
|
|
RJET
11748
Republic Airways Holdings
RJET
$861M
| $68.8K | ﹤0.01% |
3,527
-3,769
| -52% | -$66.6K |
|
|
REE
11749
CALL
DELISTED
REE Automotive
REE
| $68.7K | ﹤0.01% |
96,700
-93,800
| -49% | -$66.4K |
|
11750
Sera Prognostics
SERA
$81.7M
| $68.5K | ﹤0.01% |
22,372
-2,074
| -8% | -$5.91K |
|
Similar funds
Jeff Yass's Q3 2025 Portfolio in Review
As of Q3 2025, Jeff Yass held 14,336 positions worth $875B, up 22% from $720B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Jeff Yass's Q3 2025 filing shows 1,794 new, 5,240 increased, 5,148 reduced and 2,105 closed positions. Its largest new stake was BitMine Immersion Technologies: 7,689,603 shares worth $399M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $1.14B.
By sector, the portfolio is most concentrated in Miscellaneous at 94% of assets, up from 94% a quarter earlier, followed by Technology and Consumer Discretionary.
- Jeff Yass's largest Q3 2025 buy was BitMine Immersion Technologies: 7,689,603 shares worth $399M.
- Jeff Yass added most to Meta Platforms (Facebook) in Q3 2025, an estimated $646M increase.
- Jeff Yass's biggest Q3 2025 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.14B.
- Jeff Yass fully exited iShares Core MSCI Total International Stock ETF in Q3 2025, selling an estimated $123M.
- Jeff Yass's ten largest holdings make up 24% of its $875B portfolio in Q3 2025.
- Jeff Yass opened 1,794 new positions and closed 2,105 in Q3 2025.
- Jeff Yass's portfolio value rose 22% quarter-over-quarter to $875B.
Based on Susquehanna International Group's 13F filing for Q3 2025, filed 14 Nov 2025.